Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-19

Clinical Trial Update: Soy-Based Meal Replacement in Helping Women With Stage I, Stage II, or Stage III Breast Cancer in Complete Remission Lose Weight [NA]

View source ↗

Summary

This completed clinical trial evaluated a soy-based meal replacement for weight loss in women with stage I-III breast cancer in complete remission; the update n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Soy-based meal replacement

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Breast Cancer, Obesity | NA | Status: COMPLETED